Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hideya Kashihara is active.

Publication


Featured researches published by Hideya Kashihara.


Surgical Endoscopy and Other Interventional Techniques | 2014

Characteristics of internal hernia after gastrectomy with Roux-en-Y reconstruction for gastric cancer.

Kozo Yoshikawa; Mitsuo Shimada; Nobuhiro Kurita; Hirohiko Sato; Takashi Iwata; Jun Higashijima; Motoya Chikakiyo; Masaaki Nishi; Hideya Kashihara; Chie Takasu; Noriko Matsumoto; Syohei Eto

BackgroundAlthough the internal hernias have been a huge topic in the field of bariatric surgery, there were a few reports in gastric cancer. The purpose of this study was to analyze the incidence, clinical features, and prevention of internal hernia after gastrectomy for gastric cancer.MethodsTwelve patients who underwent surgical treatment for internal hernia in our hospital after gastrectomy were analyzed. Features, including incidence, symptoms, and signs, were investigated in detail.ResultsThe operative procedures for preceding gastrectomies were open distal gastrectomy in three patients, open total gastrectomy in three patients, laparoscopic-assisted distal gastrectomy in two patients, and laparoscopic total gastrectomy in four patients. The most frequent sites of internal hernias were jejunojejunostomy mesenteric defects (five patients) and Petersen’s defect (five patients), mesenterium of transverse colon (one patient), and esophagus hiatus (one patient). There was no significant difference between open and laparoscopic preceding gastrectomies. After closure of the mesenteric defect was introduced, no further internal hernias occurred. On CT examination, the whirl sign was present in ten patients on 3D images.ConclusionsThe present data suggest the importance of early recognition and treatment of internal hernia, as well as its prevention by closure of mesenteric defects.


Cancer Letters | 2012

Platelet-derived endothelial cell growth factor/thymidine phosphorylase inhibitor augments radiotherapeutic efficacy in experimental colorectal cancer

Tomohiko Miyatani; Nobuhiro Kurita; Tohru Utsunomiya; Takashi Iwata; Masanori Nishioka; Kozo Yoshikawa; Jun Higashijima; Hideya Kashihara; Chie Takasu; Masakazu Fukushima; Mitsuo Shimada

PURPOSES A lot of radiosensitizers have been developed. However, there are few to be available in the clinical setting. Thymidine phosphorylase inhibitor (TPI) regulates the phosphorolysis of thymidine to thymine and 2-deoxy-d-ribose-1-phosphate which is essential for tumor angiogenesis. The aim of this study is to evaluate whether TPI augments the radiotherapy for colorectal cancer in vitro and in vivo studies. MATERIALS AND METHODS The cytotoxicity of TPI with irradiation on HT29 and HCT116 cells was examined using MTT- and colony formation assay. At 10days post-inoculation, HT29 bearing orthotopic model mice (n=28) were divided into four groups and orally treated with TPI- (50mg/kg/day for 2weeks), radiation (RT, 2Gy×4: Total 8Gy), their combination or the vehicle. The mechanisms underlying the efficacy were assessed genomically and immunohistochemically. RESULTS Compared to each single treatment, the combination of TPI and RT synergistically inhibited the cell viability in a time- and dose-dependent manner. In the HT-29 bearing mice, the combination of TPI and RT reduced the tumor growth compared with RT alone. Notably, the mRNA levels of VEGF, TGF-β and, Rad51 and the protein expressions of VEGF and CD34 were significantly lower in the combination than the others. Furthermore, the combination markedly increased the TUNEL-positive cells, suggesting that TPI augments the cancer cell death through inhibition of angiogenesis and DNA repair system in the radiotherapy. CONCLUSIONS Our study first demonstrated that the combination of TPI and irradiation was effective in colon cancer. TPI would provide a promising therapeutic strategy as a radiosensitizer.


Journal of Gastroenterology and Hepatology | 2015

Duodenal–jejunal bypass improves diabetes and liver steatosis via enhanced glucagon‐like peptide‐1 elicited by bile acids

Hideya Kashihara; Mitsuo Shimada; Nobuhiro Kurita; Hirohiko Sato; Kozo Yoshikawa; Jun Higashijima; Motoya Chikakiyo; Masaaki Nishi; Chie Takasu

Bariatric surgery not only elicits weight loss but also rapidly resolves diabetes. However, the mechanisms remain unclear. The present study investigates how diabetes and liver steatosis are improved after duodenal–jejunal bypass (DJB) compared with a glucagon‐like peptide‐1 (GLP‐1) analog and correlations between bile acids and GLP‐1 secretion.


Asian Journal of Endoscopic Surgery | 2012

Short-term results of laparoscopic surgery after preoperative chemoradiation for clinically staged T3 and T4 rectal cancer

Masanori Hotchi; Mitsuo Shimada; Nobuhiro Kurita; Takashi Iwata; Hirohiko Sato; Shinya Morimoto; Kozo Yoshikawa; Jun Higashijima; Tomohiko Miyatani; Chie Mikami; Hideya Kashihara

The feasibility of laparoscopic surgery for clinically staged T3 and T4 rectal cancer has not been clearly defined specifically in cases following preoperative chemoradiation therapy (CRT). Our aim was to investigate the feasibility of laparoscopic surgery after preoperative CRT for clinically staged T3 and T4 rectal cancer.


Hepato-gastroenterology | 2011

Preoperative radiotherapy combined with S-1 for advanced lower rectal cancer: phase I trial.

Shinya Morimoto; Mitsuo Shimada; Nobuhiro Kurita; Hirohiko Sato; Takashi Iwata; Masanori Nishioka; Kozo Yoshikawa; Tomohiko Miyatani; Hideya Kashihara; Chie Takasu; Hitoshi Ikushima

BACKGROUND/AIMS S-1 based chemoradiation is the recommended treatment for rectal cancer; however, the optimal scheduling and dosing are not yet established. A Phase I study was conducted to determine the maximum tolerated dose (MTD) of S-1 with radiotherapy (RT). Endpoints were the toxicity profile of this regimen and to determine the recommended dose (RD). METHODOLOGY Conformal RT was given using 4 fields at daily fractions of 2Gy on 5 days per week to a total dose of 40Gy. Concurrently S-1 was given twice daily throughout RT. Eligible patients had a newly diagnosed clinical stage T3-4 N0-2 M0 rectal adenocarcinoma located within 12cm of the anal verge suitable for curative resection. Surgery was performed 6 weeks from completion of preoperative chemoradiotherapy. The dose escalating from S-1 80mg/m2/day (Level 1) to 100mg/m2/day (Level 2). RESULTS Nine patients were valid for safety. In all patients, S-1 was administered. There was no dose-limiting toxicity (DLT) in patients treated at dose Level 1. Six patients were enrolled in the dose-escalation phase. At dose Level 2, two patients developed DLT and this was considered the MTD. Objective response according to RECIST were observed in 5 of 9 patients who had measurable disease (56%). CONCLUSIONS The RD of S-1 with concurrent RT was determined to be 80mg/m2/day. Preoperative RT combined with S-1 was feasible and well tolerated.


Asian Journal of Endoscopic Surgery | 2016

Combined liver mobilization and retraction: A novel technique to obtain the optimal surgical field during laparoscopic total gastrectomy

Kozo Yoshikawa; Mitsuo Shimada; Jun Higashijima; Toshihiro Nakao; Masaaki Nishi; Chie Takasu; Hideya Kashihara; Syohei Eto

During laparoscopic gastrectomy, it is important to establish a good operative field and ensure an adequate working space. The combined liver mobilization and retraction method is used to get a safe and optimal view.


Asian Journal of Endoscopic Surgery | 2014

Hybrid technique for laparoscopic incisional ventral hernia repair combining laparoscopic primary closure and mesh repair

Kozo Yoshikawa; Mitsuo Shimada; Nobuhiro Kurita; Hirohiko Sato; Takashi Iwata; Jun Higashijima; Motoya Chikakiyo; Masaaki Nishi; Hideya Kashihara; Chie Takasu; Noriko Matsumoto; Syohei Eto

Incisional ventral hernia is one of the most common surgical complications after laparotomy. Laparoscopic repair of incisional ventral hernia has been conducted recently, and the advantages of this procedure have been reported. However, in large orifice cases, the recurrence rate is increased. To improve recurrence rates in large cases, a hybrid method combining laparoscopic primary closure and mesh repair can be applied.


Annals of Gastroenterological Surgery | 2018

Blue light-emitting diodes induce autophagy in colon cancer cells by Opsin 3

Toshiaki Yoshimoto; Yuji Morine; Chie Takasu; Rui Feng; Tetsuya Ikemoto; Kozo Yoshikawa; Syuichi Iwahashi; Yu Saito; Hideya Kashihara; Masatake Akutagawa; Takahiro Emoto; Yosuke Kinouchi; Mitsuo Shimada

Light emitting‐diodes (LED) have various effects on living organisms and recent studies have shown the efficacy of visible light irradiation from LED for anticancer therapies. However, the mechanism of LEDs effects on cancer cells remains unclear. The aim of the present study was to investigate the effects of LED on colon cancer cell lines and the role of photoreceptor Opsin 3 (Opn3) on LED irradiation in vitro.


The Journal of Medical Investigation | 2016

Limited lymph node dissection in elderly patients with gastric cancer

Kozo Yoshikawa; Mitsuo Shimada; Jun Higashijima; Toshihiro Nakao; Masaaki Nishi; Hideya Kashihara; Chie Takasu

BACKGROUND The number of elderly patients with gastric cancer is continuing to increase along with the life expectancy of the general population. The purpose of this study was to investigate both the impact of age on postoperative outcome and the effect of limited lymph node dissection for elderly patients. METHODS Patients were classified into the following three groups: Group A, ≥80 years old (n=44); Group B, 70-80 years old (n=139); Group C, <70 years old (n=219). Postoperative complication and survival rates were compared between the three groups Results: Limited lymph node dissection was performed significantly more frequently in Group A. In terms of surgery-related complications, no significant difference was seen between groups. In terms of general related complications, the complication rate increased with age, from 4% in Group C to 13% in Group B and 14% in Group A (p<0.05 each). Although limited lymph node dissection was frequently performed in Group A, cancer-specific survival showed no significant difference in R0 patients. CONCLUSIONS Limited lymph node dissection for gastric cancer did not affect the cancer-specific survival in elderly patients.


Surgery Today | 2015

Protein kinase Cι is a new prognostic factor in gastric cancer

Hideya Kashihara; Mitsuo Shimada; Nobuhiro Kurita; Takashi Iwata; Hirohiko Sato; Kozo Yoshikawa; Tomohiko Miyatani; Chie Takasu; Noriko Matsumoto

PurposesProtein kinase Cι (PKCι) is an important oncogenic K-ras effector, and its expression is correlated with tumor angiogenesis. The role of PKCι in gastric cancer remains unclear. The aim of this study was to clarify the role of PKCι in gastric cancer.MethodsTwenty-eight patients with gastric cancer who underwent gastrectomy were enrolled in this study. The expression of PKCι mRNA was determined, as were the clinicopathological factors. The patients were divided into PKCι high and low expression groups. The 5-year survival rate, ERK mRNA level and VEGF mRNA level were compared between the two groups. The prognostic factors were investigated by a multivariate analysis.ResultsHigh expression of PKCι was observed to be associated with a lack of differentiation, tumor invasion ≥muscularis propria≤, stage III and IV disease and peritoneal dissemination. The 5-year survival rate in the PKCι high group was lower than that in the PKCι low group. The multivariate analysis revealed that a high expression level of PKCι was an independent prognostic factor. The expression levels of ERK and VEGF in the PKCι high group were higher than those in the PKCι low group.ConclusionOur results indicate that PKCι is correlated with tumor progression and angiogenesis. PKCι may be a new prognostic factor for gastric cancer.

Collaboration


Dive into the Hideya Kashihara's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Chie Takasu

University of Tokushima

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge